Enzo Biochem (ENZ) Revenue & Revenue Breakdown
Enzo Biochem Revenue Highlights
Latest Revenue (Y)
$31.91M
Latest Revenue (Q)
$6.21M
Main Segment (Y)
Consolidated Member
Main Geography (Y)
UNITED STATES
Enzo Biochem Revenue by Period
Enzo Biochem Revenue by Year
Date | Revenue | Change |
---|---|---|
2024-07-31 | $31.91M | 2.72% |
2023-07-31 | $31.06M | -70.99% |
2022-07-31 | $107.07M | -9.05% |
2021-07-31 | $117.73M | 54.87% |
2020-07-31 | $76.02M | -6.34% |
2019-07-31 | $81.17M | -22.48% |
2018-07-31 | $104.71M | -2.87% |
2017-07-31 | $107.80M | 4.90% |
2016-07-31 | $102.77M | 5.30% |
2015-07-31 | $97.60M | 1.72% |
2014-07-31 | $95.95M | 2.39% |
2013-07-31 | $93.71M | -9.10% |
2012-07-31 | $103.08M | 1.03% |
2011-07-31 | $102.03M | 5.10% |
2010-07-31 | $97.08M | 8.38% |
2009-07-31 | $89.57M | 15.14% |
2008-07-31 | $77.80M | 47.04% |
2007-07-31 | $52.91M | 32.85% |
2006-07-31 | $39.83M | -8.24% |
2005-07-31 | $43.40M | 4.22% |
2004-07-31 | $41.64M | -21.08% |
2003-07-31 | $52.77M | -2.31% |
2002-07-31 | $54.02M | -7.52% |
2001-07-31 | $58.41M | 16.75% |
2000-07-31 | $50.03M | 12.93% |
1999-07-31 | $44.30M | 9.65% |
1998-07-31 | $40.40M | 15.76% |
1997-07-31 | $34.90M | 1.16% |
1996-07-31 | $34.50M | 8.83% |
1995-07-31 | $31.70M | 39.04% |
1994-07-31 | $22.80M | 14.00% |
1993-07-31 | $20.00M | - |
Enzo Biochem Revenue by Quarter
Date | Revenue | Change |
---|---|---|
2024-10-31 | $6.21M | -17.45% |
2024-07-31 | $7.53M | -6.18% |
2024-04-30 | $8.02M | -6.21% |
2024-01-31 | $8.55M | 9.57% |
2023-10-31 | $7.81M | -139.70% |
2023-07-31 | $-19.66M | -222.06% |
2023-04-30 | $16.11M | -1.41% |
2023-01-31 | $16.34M | -10.60% |
2022-10-31 | $18.28M | -9.90% |
2022-07-31 | $20.28M | -22.65% |
2022-04-30 | $26.22M | -22.98% |
2022-01-31 | $34.05M | 28.38% |
2021-10-31 | $26.52M | 6.88% |
2021-07-31 | $24.81M | -24.34% |
2021-04-30 | $32.80M | 4.23% |
2021-01-31 | $31.47M | 9.81% |
2020-10-31 | $28.66M | 46.75% |
2020-07-31 | $19.53M | 15.52% |
2020-04-30 | $16.90M | -12.80% |
2020-01-31 | $19.38M | -4.07% |
2019-10-31 | $20.21M | -3.41% |
2019-07-31 | $20.92M | 6.40% |
2019-04-30 | $19.66M | 1.73% |
2019-01-31 | $19.33M | -9.09% |
2018-10-31 | $21.26M | -13.06% |
2018-07-31 | $24.45M | -4.58% |
2018-04-30 | $25.63M | -4.91% |
2018-01-31 | $26.95M | -2.62% |
2017-10-31 | $27.68M | -1.76% |
2017-07-31 | $28.17M | 4.00% |
2017-04-30 | $27.09M | 3.16% |
2017-01-31 | $26.26M | -0.09% |
2016-10-31 | $26.28M | -1.20% |
2016-07-31 | $26.60M | 0.64% |
2016-04-30 | $26.43M | 7.63% |
2016-01-31 | $24.56M | -2.45% |
2015-10-31 | $25.18M | -2.02% |
2015-07-31 | $25.70M | 7.13% |
2015-04-30 | $23.99M | 3.87% |
2015-01-31 | $23.09M | -6.98% |
2014-10-31 | $24.82M | -0.33% |
2014-07-31 | $24.91M | 3.87% |
2014-04-30 | $23.98M | 4.58% |
2014-01-31 | $22.93M | -5.00% |
2013-10-31 | $24.13M | 3.71% |
2013-07-31 | $23.27M | 2.97% |
2013-04-30 | $22.60M | 1.75% |
2013-01-31 | $22.21M | -13.34% |
2012-10-31 | $25.63M | -2.95% |
2012-07-31 | $26.41M | 1.78% |
2012-04-30 | $25.95M | 3.91% |
2012-01-31 | $24.97M | -3.03% |
2011-10-31 | $25.75M | -3.96% |
2011-07-31 | $26.82M | 3.83% |
2011-04-30 | $25.83M | 8.82% |
2011-01-31 | $23.73M | -7.48% |
2010-10-31 | $25.65M | 2.83% |
2010-07-31 | $24.95M | 4.86% |
2010-04-30 | $23.79M | 2.60% |
2010-01-31 | $23.19M | -7.86% |
2009-10-31 | $25.16M | 2.58% |
2009-07-31 | $24.53M | 6.37% |
2009-04-30 | $23.06M | 10.26% |
2009-01-31 | $20.92M | -0.70% |
2008-10-31 | $21.06M | -0.53% |
2008-07-31 | $21.18M | 11.75% |
2008-04-30 | $18.95M | 3.97% |
2008-01-31 | $18.23M | - |
Enzo Biochem Revenue Breakdown
Enzo Biochem Revenue Breakdown by Product
Annual Revenue by Product
Product/Service | Jul 22 | Jul 21 | Jul 20 | Jul 19 | Jul 18 |
---|---|---|---|---|---|
Consolidated Member | $107.07M | - | - | - | - |
LifeSciencesProductsMember | - | $30.75M | - | - | - |
ClinicalLaboratoryServicesMember | - | $86.98M | - | - | - |
ConsolidatedMember | - | $117.73M | - | - | - |
ClinicalServicesMember | - | - | $24.89M | - | - |
ClinicalServicesThreeMember | - | - | $5.98M | - | - |
ClinicalServices1Member | - | - | $10.82M | - | - |
ClinicalServicesTwoMember | - | - | $6.26M | - | - |
Clinical Labs | - | - | - | $51.12M | - |
Consolidated | - | - | - | $81.17M | $104.71M |
Life Sciences | - | - | - | $30.05M | $29.94M |
Latest
Quarterly Revenue by Product
Product/Service | Jul 22 | Apr 22 | Jan 22 | Oct 21 | Jul 21 | Apr 21 | Jan 21 | Oct 20 | Apr 20 | Jan 20 | Oct 19 | Jul 19 | Apr 19 | Jan 19 | Oct 18 | Jul 18 | Apr 18 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Consolidated Member | $20.28M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
ClinicalServicesMember | - | $18.63M | $23.67M | $16.75M | $21.22M | $9.74M | - | - | - | - | - | - | - | - | - | - | - |
ProductsMember | - | $7.59M | $10.37M | $6.78M | $7.78M | $7.48M | - | - | - | - | - | - | - | - | - | - | - |
ConsolidatedMember | - | $26.22M | $34.05M | $26.52M | $32.80M | $31.47M | - | - | - | - | - | - | - | - | - | - | - |
ClinicalLabsMember | - | - | - | $19.74M | $25.02M | $23.99M | - | - | - | - | - | - | - | - | - | - | - |
ClinicalServices1Member | - | - | - | - | - | - | - | $3.26M | $9.74M | - | - | - | - | - | - | - | - |
ClinicalServicesThreeMember | - | - | - | - | - | - | - | $1.87M | $1.13M | - | - | - | - | - | - | - | - |
ClinicalServicesTwoMember | - | - | - | - | - | - | - | $2.56M | $1.66M | - | - | - | - | - | - | - | - |
Product Revenue | - | - | - | - | - | - | - | - | - | $6.87M | $7.43M | - | - | - | - | - | - |
Life Sciences | - | - | - | - | - | - | - | - | - | - | - | $7.85M | $7.68M | $7.49M | - | - | - |
Consolidated | - | - | - | - | - | - | - | - | - | - | - | $20.92M | $19.66M | $19.33M | $21.26M | $24.45M | $25.63M |
Clinical Services | - | - | - | - | - | - | - | - | - | - | - | - | $11.75M | $12.00M | $14.30M | - | - |
Products | - | - | - | - | - | - | - | - | - | - | - | - | $7.91M | $7.33M | $6.96M | - | - |
Clinical Labs | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | $16.78M | $18.14M |
Latest
Enzo Biochem Revenue Breakdown by Country
Annual Revenue by Country
Country | Jul 24 | Jul 23 | Jul 22 | Jul 21 | Jul 20 |
---|---|---|---|---|---|
Asia Pacific | $3.86M | $4.06M | $4.29M | $4.74M | - |
Europe | $8.56M | $8.45M | $8.57M | $10.39M | - |
UNITED STATES | $19.49M | $18.55M | $19.78M | $102.60M | - |
Consolidated Member | - | - | $107.07M | - | - |
RestofworldMember | - | - | - | - | $4.50M |
European Union | - | - | - | - | $7.48M |
Latest
Quarterly Revenue by Country
Country | Oct 24 | Jul 24 | Apr 24 | Jan 24 | Oct 23 | Jul 23 | Apr 23 | Jan 23 | Oct 22 | Jul 22 | Jan 22 | Oct 21 | Jul 21 | Apr 21 | Jan 21 | Oct 20 | Apr 20 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
UNITED STATES | $3.76M | $4.89M | $4.79M | $5.17M | $4.63M | $5.27M | $5.04M | $4.14M | $4.09M | $6.75K | $3.86K | $3.46M | - | - | - | - | - |
Asia Pacific | $785.00K | $854.00K | $870.00K | $1.10M | $1.03M | $1.11M | $754.00K | $1.09M | $1.10M | $1.22K | $908.00 | $1.11M | $1.32M | - | - | - | - |
Europe | $1.66M | $1.78M | $2.36M | $2.29M | $2.14M | $2.58M | $1.69M | $2.28M | $1.90M | - | - | - | - | - | - | - | - |
Consolidated Member | - | - | - | - | - | - | - | - | - | $20.28M | - | - | - | - | - | - | - |
European Union | - | - | - | - | - | - | - | - | - | - | $2.40K | $2.01K | $2.59M | $2.73M | $2.63M | $2.38M | $1.79M |
RestofworldMember | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | $1.17M | $1.17M |
Latest
Enzo Biochem Peer Comparison by Revenue
Ticker | Company | Last Year Revenue | Last Quarter Revenue |
---|---|---|---|
FONR | FONAR | $102.88B | $25.94M |
SHC | Sotera Health Company | $1.05B | $285.47M |
BNR | Burning Rock Biotech | $537.43M | $125.62M |
CSTL | Castle Biosciences | $219.79M | $85.78M |
STIM | Neuronetics | $71.35M | $16.45M |
XGN | Exagen | $52.55M | $15.06M |
BDSX | Biodesix | $49.09M | $18.15M |
ENZ | Enzo Biochem | $31.91M | $6.21M |
PMD | Psychemedics | $22.10M | $5.17M |
DRIO | DarioHealth | $20.35M | $6.25M |
SERA | Sera Prognostics | $306.00K | $24.00K |